NCT06681233 - Feasibility Study of CBCT for IGRT in Cancer Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 19, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

September 30, 2026

Conditions

Head and Neck CancersBreast CancerThoracic CancersLiver CancerGenito Urinary CancerGastrointestinal Cancers

Interventions

DEVICE

Comparison of HyperSight CBCT imaging to conventional CBCT imaging.

Participants will receive their daily radiation treatment on a radiation therapy system equipped with HyperSight CBCT imaging. For at least 1 and up to 3 treatment fractions, participants will receive their daily radiation treatment on a system equipped with conventional CBCT imaging.

Trial Locations (2)

43210

RECRUITING

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus

43212

RECRUITING

Stefanie Spielman Comprehensive Breast Center, Columbus

All Listed Sponsors

lead

Varian, a Siemens Healthineers Company

INDUSTRY